- Home
- BDSX vs PLL Comparison
BDSX vs PLL Comparison
Compare BDSX & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- PLL
- Stock Information
- Founded
- BDSX 2005
- PLL 2016
- Country
- BDSX United States
- PLL United States
- Employees
- BDSX N/A
- PLL N/A
- Industry
- BDSX Precision Instruments
- PLL Other Metals and Minerals
- Sector
- BDSX Health Care
- PLL Basic Materials
- Exchange
- BDSX Nasdaq
- PLL Nasdaq
- Market Cap
- BDSX 245.3M
- PLL 238.0M
- IPO Year
- BDSX 2020
- PLL 2017
- Fundamental
- Price
- BDSX $1.60
- PLL $10.53
- Analyst Decision
- BDSX Strong Buy
- PLL Buy
- Analyst Count
- BDSX 4
- PLL 8
- Target Price
- BDSX $3.08
- PLL $24.05
- AVG Volume (30 Days)
- BDSX 118.2K
- PLL 1.3M
- Earning Date
- BDSX 11-01-2024
- PLL 11-04-2024
- Dividend Yield
- BDSX N/A
- PLL N/A
- EPS Growth
- BDSX N/A
- PLL N/A
- EPS
- BDSX N/A
- PLL N/A
- Revenue
- BDSX $60,902,000.00
- PLL $66,444,999.00
- Revenue This Year
- BDSX $48.06
- PLL $191.48
- Revenue Next Year
- BDSX $29.97
- PLL $5.47
- P/E Ratio
- BDSX N/A
- PLL N/A
- Revenue Growth
- BDSX 46.25
- PLL N/A
- 52 Week Low
- BDSX $1.15
- PLL $6.57
- 52 Week High
- BDSX $2.21
- PLL $31.82
- Technical
- Relative Strength Index (RSI)
- BDSX 39.90
- PLL 48.00
- Support Level
- BDSX $1.59
- PLL $12.70
- Resistance Level
- BDSX $1.68
- PLL $15.14
- Average True Range (ATR)
- BDSX 0.06
- PLL 1.47
- MACD
- BDSX -0.01
- PLL -0.23
- Stochastic Oscillator
- BDSX 20.51
- PLL 27.26
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About PLL Piedmont Lithium Inc.
Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.